GenesisCare Murdoch

Running trials

• Recruiting

  A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors

  NCT07661641· Phase 1· Source

• Recruiting

  Study With [225Ac]Ac-FL-020 in mCRPC Participants

  NCT06492122· Phase 1· Source

• Recruiting

  177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

  NCT06305962· Early phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer2 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Head and neck cancer1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

  NCT07076550· Phase 1· Source

• Terminated

  The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

  NCT04876651· Phase 3· Source